Lidocaine

Product NDC: 17478-711
11-digit product format: 174780711
Labeler code: 17478
Product ID: 17478-711_cabfb396-7b14-40b5-a647-634e907e2d3c
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Lidocaine Hydrochloride
Dosage form: JELLY
Route: TOPICAL
Labeler: Akorn
Application: ANDA040433
Marketing category: ANDA
Marketing start: 2003-08-01
Marketing end: 0000-00-00
Substance: LIDOCAINE HYDROCHLORIDE
Active strength: 20 mg/mL
Pharmacologic classes: Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE]
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 4 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	17478-711		I	Inactivated by FDA	2026-08-03
excluded package	package	17478-711	17478-711-10	I	Inactivated by FDA	2026-08-03
excluded package	package	17478-711	17478-711-30	I	Inactivated by FDA	2026-08-03
excluded package	package	17478-711	17478-711-31	I	Inactivated by FDA	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 60 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-711-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-711-30	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	17478-711-31	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-711-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-711-30	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	17478-711-31	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-711-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-711-30	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	17478-711-31	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-711-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-711-30	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	17478-711-31	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-711-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-711-30	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	17478-711-31	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-711-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-711-30	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	17478-711-31	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-711-10	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-711-30	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	17478-711-31	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-711-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-711-30	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	17478-711-31	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-711-10	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-711-30	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	17478-711-31	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-711-10	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-711-30	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	17478-711-31	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-711-10	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-711-30	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	17478-711-31	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-711-10	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-711-30	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	17478-711-31	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	17478-711-10	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	17478-711-30	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	17478-711-31	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17478-711-10	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17478-711-30	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	17478-711-31	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17478-711-10	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17478-711-30	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	17478-711-31	`1332a3947898…`	`d4bfe170f9cd…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A040433-001	LIDOCAINE HYDROCHLORIDE	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A040433-001	AT

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT		2003-02-12	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040433-001	LIDOCAINE HYDROCHLORIDE	2%	JELLY / TOPICAL	AT	RS	2003-02-12	`cb3db0bc1861…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A040433-001	AT	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A040433-001	AT	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A040433-001	AT	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A040433-001	AT	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A040433-001	AT	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A040433-001	AT	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A040433-001	AT	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A040433-001	AT	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A040433-001	AT	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A040433-001	AT	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A040433-001	AT	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A040433-001	AT	1	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A040433-001	AT	1	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A040433-001	AT	1	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A040433-001	AT	1	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A040433-001	AT	1	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A040433-001	AT	1	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A040433-001	AT	1	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A040433-001	AT	1	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A040433-001	AT	1	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A040433-001	AT	1	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A040433-001	AT	1	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A040433-001	AT	1	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A040433-001	AT	1	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A040433-001	AT	1	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A040433-001	AT	1	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A040433-001	AT	1	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A040433-001	AT	1	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A040433-001	AT	1	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A040433-001	AT	1	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A040433-001	AT	1	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A040433-001	AT	1	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A040433-001	AT	1	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A040433-001	AT	1	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A040433-001	AT	1	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A040433-001	AT	1	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A040433-001	AT	1	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A040433-001	AT	1	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A040433-001	AT	1	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A040433-001	AT	1	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
070fbed5-7088-434a-a7ce-f2a64d8d40ac	Product name	2	20260107
bee66ce1-adb7-9d3b-67d9-582e4c54e80f	Product name	5	20250819
860a93dc-4863-49cc-b284-6bbe8191bc48	Product name	4	20250214
eaba870a-6a9d-442e-8643-87b3f558a451	Product name	1	20250117
9b4cf230-fd05-41d5-98c6-5db9ecb27b86	Product name	1	20230117
7d755fa1-1087-4dcd-98f0-6d4bba479a57	Product name	3	20210602
aed701d5-9c75-dfaf-7154-cde46179faea	Product name	9	20200313
fa8b5901-e681-426f-82fe-54f6d81ec698	Product name	4	20180619
332d03e4-aa24-4b11-841a-02bf41081920	Product name	1	20171221
c08ab52f-2fc8-4409-9d9f-ed8edc0bd070	Product name	1	20171221
68ed98f8-24c2-44a0-944a-6d36e82ce25a	Product name	1	20141222
1cd42bc2-a430-c72b-636d-991b235fbf80	Product name	1	20140508
49fa150c-f0de-cce7-3d9c-993ed81c5698	Product name	1	20140508
4d7ae718-ed00-bae8-2abe-9eaec1eef7ff	Product name	1	20140508
9137811f-f279-8640-5aeb-99fa2145d64d	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
17478-711-10	2024-01-30	C162847	48780-1	1030e365-10a1-111a-e063-dadaa90a10e2	Lidocaine Hydrochloride Jelly USP, 2%
17478-711-30	2024-01-30	C162847	48780-1	1030e365-10a1-111a-e063-dadaa90a10e2	Lidocaine Hydrochloride Jelly USP, 2%
17478-711-31	2024-01-30	C162847	48780-1	1030e365-10a1-111a-e063-dadaa90a10e2	Lidocaine Hydrochloride Jelly USP, 2%

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
17478-711-10	Lidocaine	1 in 1 CARTON	JELLY	1	8
17478-711-10	Lidocaine	5 mL in 1 TUBE	JELLY	5	8
17478-711-30	Lidocaine	1 in 1 CARTON	JELLY	1	8
17478-711-30	Lidocaine	30 mL in 1 TUBE, WITH APPLICATOR	JELLY	30	8
17478-711-31	Lidocaine	10 in 1 CARTON	JELLY	10	8
17478-711-31	Lidocaine	5 mL in 1 TUBE	JELLY	5	8

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
17478-711-10	ML - Milliliter	17478-711	c3d33659-1892-4ac2-9e7c-97c2466ae6c6	1	2012-07-24
17478-711-30	ML - Milliliter	17478-711	06b9955a-242d-4216-a70f-ea70550576ad	1	2012-07-24
17478-711-31	ML - Milliliter	17478-711	3f0c6e2c-db02-4a07-b9da-e7144837a00c	1	2019-10-07

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Lidocaine Hydrochloride	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
Lidocaine Hydrochloride	ACTIVE INGREDIENT	V13007Z41A	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1
Lidocaine	ACTIVE MOIETY	98PI200987	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
Lidocaine	ACTIVE MOIETY	98PI200987	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
Hydrochloric Acid	INACTIVE INGREDIENT	QTT17582CB	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1
Hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
Hypromelloses	INACTIVE INGREDIENT	3NXW29V3WO	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1
Propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
Propylparaben	INACTIVE INGREDIENT	Z8IX2SC1OH	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN, INC.]	1
Sodium Hydroxide	INACTIVE INGREDIENT	55X04QC32I	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [PHYSICIANS TOTAL CARE, INC.]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
17478-711	LIDOCAINE (LIDOCAINE HYDROCHLORIDE) JELLY [AKORN]	8	Legacy NDC, 6 package rows	20220914_317a8784-5fdd-429f-9b74-14d89f372a32.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lidocaine	LIDOCAINE HYDROCHLORIDE	ARMAS PHARMACEUTICALS INC.	2f6e0f3d-ceaf-a853-e063-6394a90a8efb	2025-03-07	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 040433 application number: ANDA040433

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
V13007Z41A	LIDOCAINE HYDROCHLORIDE	6108-05-0	LIDOCAINE HYDROCHLORIDE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
1011852	lidocaine HCl 2 % Topical Gel	PSN	3ca876de-04bf-43e4-95d4-a58acc0d26c5	10
1011852	lidocaine hydrochloride 0.02 MG/MG Topical Gel	SCD	3ca876de-04bf-43e4-95d4-a58acc0d26c5	10
1011852	lidocaine hydrochloride 2 % Topical Jelly	SY	3ca876de-04bf-43e4-95d4-a58acc0d26c5	10
1011852	lidocaine HCl 2 % Topical Gel	PSN	317a8784-5fdd-429f-9b74-14d89f372a32	8
1011852	lidocaine hydrochloride 0.02 MG/MG Topical Gel	SCD	317a8784-5fdd-429f-9b74-14d89f372a32	8
1011852	lidocaine hydrochloride 2 % Topical Jelly	SY	317a8784-5fdd-429f-9b74-14d89f372a32	8
1011852	lidocaine HCl 2 % Topical Gel	PSN	d397fcf6-49f0-4bf6-a326-4b9698a77859	1
1011852	lidocaine hydrochloride 0.02 MG/MG Topical Gel	SCD	d397fcf6-49f0-4bf6-a326-4b9698a77859	1
1011852	lidocaine hydrochloride 2 % Topical Jelly	SY	d397fcf6-49f0-4bf6-a326-4b9698a77859	1

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
17478-711-10	17478071110	1 TUBE in 1 CARTON (17478-711-10) > 5 mL in 1 TUBE	1 tube	2003-08-01	0000-00-00	No	No	Current
17478-711-30	17478071130	1 TUBE, WITH APPLICATOR in 1 CARTON (17478-711-30) > 30 mL in 1 TUBE, WITH APPLICATOR		2003-08-01	0000-00-00	No	No	Current
17478-711-31	17478071131	10 TUBE in 1 CARTON (17478-711-31) > 5 mL in 1 TUBE	10 tube	2018-05-02	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Lidocaine Hydrochloride Jelly USP, 2%	Akorn	2022-09-12	HUMAN PRESCRIPTION DRUG LABEL	8
Lidocaine Hydrochloride Jelly USP, 2%	A-S Medication Solutions	2021-04-14	HUMAN PRESCRIPTION DRUG LABEL	10
Lidocaine Hydrochloride Jelly USP,2%	Physicians Total Care, Inc.	2012-03-22	HUMAN PRESCRIPTION DRUG LABEL	1